S.Biomedics Selects Parexel as US Clinical CRO... Accelerating Entry into Japanese Market
S.Biomedics has selected Parexel, a global clinical development specialist, as its clinical trial partner for the US and Japan clinical development of its Parkinson's disease cell therapy, TED-A9, accelerating its entry into the Japanese market.
Get high-impact news instantly
Top stories with score 8/10+ delivered to your Telegram in real time. Free.
Join Telegram channel